WADA says athletes could escape meldonium ban

Image
AFP Montreal
Last Updated : Apr 14 2016 | 10:13 AM IST
The World Anti-Doping Agency (WADA) has said athletes could escape a ban for taking meldonium because it does not know for sure how long it takes the substance to leave the body.
Meldonium was banned on January 1 and WADA said there have since been 172 test failures, including Russian tennis star Maria Sharapova.
Russia has been particularly badly hit by the meldonium scandal with track and field athletes and swimmers among about 40 Russians caught.
WADA said that for meldonium, which has been used to treat heart disease and diabetes but also enhances athletic performance, "there is currently a lack of clear scientific information on excretion times".
"For this reason, a hearing panel might justifiably find (unless there is specific evidence to the contrary) that an athlete who has established on the balance of probabilities that he or she ingested meldonium before January 1, 2016 could not reasonably have known or suspected that the meldonium would still be present in his or her body on or after 1 January 2016.
"In these circumstances, WADA considers that there may be grounds for no fault or negligence on the part of the athlete."
WADA president Craig Reedie said: "Since meldonium was
prohibited on January 1 of this year, there have been 172 positive samples for the substance, for athletes across numerous countries and sports."
He said countries had been calling for "further clarification and guidance" on how to police meldonium.
"WADA recognizes this need -- that meldonium is a particular substance, which has created an unprecedented situation and therefore warranted additional guidance for the anti-doping community."
WADA officials said the new studies would concentrate on how long it takes meldonium to get out of the system.
As Russian athletes -- including Sharapova -- have borne the brunt of the meldonium scandal, the country quickly welcomed the new WADA guidance.
"The Russian sports ministry supports and welcomes WADA for approaching the problem of meldonium not in a formulaic way, by immediately punishing all athletes, but instead demonstrating a desire to understand the situation," said a ministry statement.
"WADA has demonstrated impartiality and an objective approach in fighting doping."
Meldonium increases blood flow and so can help athletes improve their performance.
Tennis star Sharapova said she tested positive for meldonium at the Australian Open in January but has denied any wrongdoing. Her key sponsor Nike suspended its backing for her.
Sharapova's lawyer John Haggerty, said in a statement that WADA's latest guidelines showed "how poorly they handled issues relating to meldonium in 2015".
"Given the fact that scores of athletes have tested positive for taking what previously was a legal product, it's clear WADA did not handle this properly last year and they're trying to make up for it now," Haggerty said.
The International Biathlon Union said last week it would not rule on any more meldonium cases until more was known about the drug.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 14 2016 | 10:13 AM IST

Next Story